NewsOur Response to a Massive Fire in Itoigawa City, Niigata
NewsDenka Presents at the 10th Japan-China Energy Conservation and Environment Forum an Agreement to License Its Technologies for Fused Calcium Carbide Transportation
NewsNotice regarding Withdrawal from the Malonic Ester Business
IR InformationFY2016 First Half Summary of Consolidated Financial Results
IR InformationFY2016 First Half Summary of Consolidated Financial Statements
NewsDenka Seiken to Expand Its Healthcare-Related Operations via a Business Alliance with the Taiwan-based PlexBio Co., Ltd.
NewsPrice revision for Denka Chloroprene
IR InformationFY2016 First Quarter Summary of Consolidated Financial Results
IR InformationFY2016 First Quarter Summary of Consolidated Financial Statements
NewsDenka to Establish a Life Science R&D Base in Biopolis in Singapore
NewsDenka Seiken to Establish a Production Facility for the G47¦¤ Oncolytic Virus
NewsDenka Signs a Comprehensive Industry-Academia Partnership Agreement with Niigata University
IR InformationDenka Corporate Governance Guidelines
IR InformationCorporate Governance Report
NewsDenka to Establish the Automotive Materials & Solutions Department
IR InformationDisclosure on the Internet accompanying the Notice of Convocation of the 157th Ordinary General Meeting of Shareholders
IR InformationNotice of Convocation of the 157th Ordinary General Meeting of Shareholders
NewsNotice regarding a Change in Division Name
NewsDenka Announces "The Denka Value," a New Corporate Philosophy
IR InformationFY2015 Summary of Consolidated Financial Results
IR InformationFY2015 Summary of Consolidated Financial Statements
NewsDenka Acquires Majority Stake in PT ESTOP INDONESIA, Making It a Group Subsidiary
IR InformationNotice Regarding Results of Treasury Stock Acquisition and Completion of Acquisition
NewsCeremonies Marking the 101st Anniversary of Denka's Founding and Welcoming New Employees
IR InformationNotice Regarding Status of Treasury Stock Acquisition
NewsDenka Group Company Denka Seiken Completes a New Manufacturing Facility at Kagamida Plant
NewsDenka Seiken to Commence Clinical Trial of an Intradermal Influenza Vaccine
NewsBEIJING STRONG BIOTECHNOLOGIES Obtains Beijing FDA Approval for the Production and Sale of a Diagnostic Reagent for the Measurement of the sd LDL-C Heart Disease Risk Marker
NewsNotice Regarding Changes in Executive Personnel
IR InformationNotice Regarding Resolution of Treasury Stock Acquisition
NewsDenka to Streamline the Chiba Plant's Utilities to Boost Competitiveness
IR InformationFY2015 Thrid Quarter Summary of Consolidated Financial Results
IR InformationFY2015 Third Quarter Summary of Consolidated Financial Statements
NewsNew Year's Message
